The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia

Area of Science:

• Hematology
• Hepatology
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) is a prevalent leukemia in Western countries.
• CLL involves long-lived leukemic cells that can infiltrate organs, especially the reticulo-endothelial system.
• Hepatic manifestations in CLL patients are common and diverse, necessitating careful evaluation.

Purpose of the Study:

• To review and summarize published literature on hepatic manifestations in chronic lymphocytic leukemia (CLL).
• To highlight the range of liver disorders associated with CLL, including leukemic infiltration, autoimmune issues, drug toxicity, and malignancies.
• To emphasize the importance of early diagnosis and management to prevent severe complications.

Main Methods:

• Comprehensive literature review of hepatic manifestations in CLL.
• Analysis of conditions including leukemic infiltration, autoimmune dysfunction, drug-induced liver toxicity, and associated malignancies.
• Discussion of diagnostic approaches, including liver biopsy when indicated.

Main Results:

• CLL can lead to liver enlargement and elevated liver enzymes due to leukemic infiltration.
• Differential diagnosis of liver disorders in CLL is broad, encompassing autoimmune conditions, infections, drug toxicity, and malignancies.
• Richter transformation is a critical consideration in CLL patients with liver involvement.

Conclusions:

• Hepatic manifestations in CLL are frequent and varied, ranging from direct infiltration to indirect effects.
• A high index of suspicion and thorough diagnostic workup are essential for managing liver complications in CLL.
• Prompt diagnosis and appropriate treatment are vital to avert fatal outcomes such as acute liver failure.